Experience
Cephalon, Inc.
Sun Pharmaceuticals
Successfully represented Cephalon against generic challenges to its patent portfolio.
Cephalon, Inc. v. Sun Pharmaceuticals, 3:11-cv-05474, D.N.J., Judges Arpert, Shipp, Wolfson
Incyte Corporation et al. v. Sun Pharmaceutical Industries Limited et al.
Incyte Corporation et al.
Medicis Pharmaceutical Corp. v. Zydus Pharmaceuticals (USA) Inc.
Medicis Pharmaceutical Corp.
Valeant Pharmaceuticals NA, LLC v. Zydus Pharmaceuticals, Inc.
Valeant Pharmaceuticals NA, LLC
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.
Otsuka Pharmaceutical Co.
Medicis Pharmaceutical Corp. v. Apotex, Inc.
Medicis Pharmaceutical Corp.
Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc.
Valeant; Salix; Progenics
Elan Pharmaceuticals, Inc. v. Ivax Pharmaceuticals, Inc.
Elan Pharmaceuticals, Inc.
Ferring B.V. v. Watson Laboratories, Inc.
Ferring B.V.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.